LCTX · CIK 0000876343 · operating
Lineage Cell Therapeutics, Inc. (LCTX) is a biological products, (no diagnostic substances) company incorporated in CA, listed on the NYSE. With a market capitalization of $449 million, Lineage Cell Therapeutics, Inc. is a small-cap company. The stock currently trades at $1.89, down 3.33% today, with a 52-week range of $0.37–$2.09.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.09 | $-0.09 | -200.0% | |
| 2023 | $-0.03 | $-0.03 | +0.0% | |
| 2022 | — | $-0.03 | +82.4% | |
| 2021 | — | $-0.17 | -1800.0% | |
| 2020 | — | $0.01 | +133.3% | |
| 2019 | — | $-0.03 | +91.7% | |
| 2018 | — | $-0.36 | -111.8% | |
| 2017 | $-0.17 | $-0.58 | -150.0% | |
| 2016 | $0.34 | $0.35 | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-10 | 0000950170-25-036309 | SEC ↗ |
| 2023-12-31 | 2024-03-07 | 0000950170-24-027988 | SEC ↗ |
| 2022-12-31 | 2023-03-09 | 0001493152-23-007129 | SEC ↗ |
| 2021-12-31 | 2022-03-10 | 0001493152-22-006520 | SEC ↗ |
| 2020-12-31 | 2021-03-11 | 0001493152-21-005814 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001493152-20-003818 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001493152-19-003335 | SEC ↗ |
| 2017-12-31 | 2018-03-15 | 0001493152-18-003416 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001140361-17-012402 | SEC ↗ |
| 2015-12-31 | 2016-03-15 | 0001140361-16-057879 | SEC ↗ |
| 2014-12-31 | 2015-03-11 | 0001140361-15-011259 | SEC ↗ |
| 2013-12-31 | 2014-03-17 | 0001140361-14-013083 | SEC ↗ |
| 2012-12-31 | 2013-03-18 | 0001140361-13-012991 | SEC ↗ |
| 2011-12-31 | 2012-03-14 | 0001140361-12-015539 | SEC ↗ |